Delivery Order SPE2DB20D7066-SPE2DB25FC4RE
- Not listed
- The Defense Logistics Agency (DLA) awarded a $1,713.12 delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Testosterone Cypionate 2,000 mg/10mL vials. This competitively awarded, non-set-aside contract features firm fixed pricing and a delivery completion date of August 6, 2025. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a single transaction under the company's broader...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,761.52 on July 22, 2025, for the supply of Testosterone Cypionate 2,000 mg/10mL vials. This firm fixed-price delivery order, which is not set-aside designated, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. The award represents a single-item pharmaceutical procurement supporting military healthcare supply...
- The Defense Logistics Agency awarded a delivery order valued at $1,404.76 to AmerisourceBergen Drug Corp for the supply of Testosterone Cypionate 1,000 mg/10 mL (10 mL vials). This non-set-aside contract was executed on August 5, 2025, with an ultimate completion date of August 6, 2025, utilizing firm fixed-price terms. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,569.66 for Testosterone Cypionate 200 mg/mL on July 23, 2025, with an ultimate completion date of July 24, 2025. This firm fixed-price, competitively awarded delivery order represents a continuation of pharmaceutical supply services to support federal medical procurement needs. The contract was not issued under any set-aside program and will be performed at the contractor's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,132.86 to AmerisourceBergen Drug Corp for Testosterone Cypionate 200 mg/mL on September 10, 2025, with an ultimate completion date of September 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement fulfilling federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,528.26 to AmerisourceBergen Drug Corp for the supply of Testosterone Cypionate 200 mg/mL on August 7, 2025, with an ultimate completion date of August 8, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- This delivery order, awarded August 29, 2025, grants AmerisourceBergen Drug Corp a $1,449.00 firm fixed price contract for Testosterone Cypionate 200 mg/mL, with completion scheduled for September 2, 2025. The award was issued by the Defense Logistics Agency under a non-set-aside competitive procurement. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's broader Indefinite...
- The Defense Logistics Agency awarded a $2,117.00 delivery order to AmerisourceBergen Drug Corp for Testosterone Cypionate 200 mg/mL on July 23, 2025, with completion expected by July 24, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The contract carries no set-aside designation and will be...
- The Defense Logistics Agency awarded a delivery order valued at $1,207.32 to AmerisourceBergen Drug Corp for the supply of Testosterone Cypionate 200 mg/mL. This firm fixed-price contract, awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a non-competitive set-aside arrangement and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's broader pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $1,942.58 to AmerisourceBergen Drug Corp for the supply of Testosterone Cypionate 1,000 mg/10 mL vials. This firm fixed price contract was awarded on August 20, 2025, with an ultimate completion date of August 21, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a non-set-aside, competitively awarded transaction and falls under AmerisourceBergen's larger...
- SPE2DB20D7066Indefinite Delivery Contract
- SPE2DB20D7066-SPE2DB25FC4REDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Testosterone Cypionate 1,000 mg/10 mL vials with a contract ceiling value of $1,266.90. This is a firm fixed-price delivery order with an ultimate completion date of September 10, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award utilized no set-aside designation, indicating it was competitively awarded through open competition. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor, AmerisourceBergen supplies critical medical commodities including specialty medications, generic drugs, and medical supplies to support military healthcare programs globally. The company's role as a pharmaceutical prime vendor enables it to serve the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, with this specific delivery order contributing to the broader pharmaceutical supply chain supporting Department of Defense medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 9/9/25 |